Filedby the Registrant
|
x
|
Filedby a Party other than the Registrant
|
o
|
o
|
Preliminary proxy statement.
|
o
|
Confidential, for use of the Commission only (as permitted by Rule 14a-6(e)(2)). |
o
|
Definitive proxy statement. |
x
|
Definitive additional materials.
|
o
|
Soliciting material pursuant to § 240.14a-12.
|
x
|
No fee required.
|
o |
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
(1)
|
Title of each class of securities to which transaction applies:
|
(2)
|
Aggregate number of securities to which transaction applies:
|
(3) |
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
(4)
|
Proposed maximum aggregate value of transaction:
|
(5)
|
Total fee paid:
|
o
|
Fee paid previously with preliminary materials.
|
o
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing.
|
(1)
|
Amount Previously Paid:
|
(2)
|
Form, Schedule or Registration Statement No.:
|
(3)
|
Filing Party:
|
(4)
|
Date Filed:
|
Antares Pharma, Inc. | |
Princeton Crossroads Corporate Center | |
250 Phillips Boulevard Suite 290 | |
Ewing, NJ 08618 | proxy |
Shareowner ServicesSM
|
|
P.O. Box 64945 | |
St. Paul, MN 55164-0945 | |
1. | To elect two members of the | 01 | Mr. Anton G.Gueth | o | Vote FOR all | o | Vote WITHHELD |
Company’s Board of Directors | 02 | Mr. Eamonn P. Hobbs | nominees | from all nominees | |||
for a term of three years. | (except as marked) |
(Instructions: To withhold authority to vote for any indicated nominee, | |
write the number(s) of the nominee(s) in the box provided to the right.) |
2. |
To hold an advisory vote to approve our executive compensation
programs.
|
For
o
|
Against
o
|
Abstain
o
|
3. |
To ratify the appointment of KPMG LLP as our independent registered
public accounting firm for our fiscal year ending December 31, 2012.
|
For
o
|
Against
o
|
Abstain
o
|
4. | To transact other business that may properly come before the meeting. |
Address Change? Mark Box o Indicate changes below:
|
Date
|
, 2012 |
Signature(s) In Box
Please sign exactly as your name(s) appears on Proxy. If held in joint tenancy, all persons should sign. Trustees, administrators, etc., should include title and authority. Corporations should provide full name of corporation and title of authorized officer signing the proxy.
|